Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.

AIDS research and therapy - 21 Apr 2021

Musana Hellen, Ssensamba Jude Thaddeus, Nakafeero Mary, Mugerwa Henry, Kiweewa Flavia Matovu, Serwadda David, Ssali Francis

Abstract excerpt

INTRODUCTION: Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if we are to minimize the number of PLHIV switched to costly third-line ART. Our study investigated the factors associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Protease Inhibitors

Share to Treatment Failure

Share to Uganda

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 33882938
DOI: 10.1186/s12981-021-00338-y
PMCID: PMC8059285

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.PMID 33882938Read ↗

Predictors of Failure on Second-line Antiretroviral Therapy with Protease Inhibitor Mutations in UgandaSemantic proximity Read ↗

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.Semantic proximity Read ↗

Determinants of virological failure and antiretroviral drug resistance in Mozambique.Semantic proximity Read ↗

Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.Semantic proximity Read ↗

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa.Semantic proximity Read ↗

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.Semantic proximity Read ↗

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.Semantic proximity Read ↗

Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.Semantic proximity Read ↗

Empiric tuberculosis treatment and 12-month mortality among sputum GeneXpert-negative adults living with HIV in Uganda in the era of widespread Antiretroviral therapy: A prospective cohort studySemantic proximity Read ↗

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.Semantic proximity Read ↗

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.Semantic proximity Read ↗

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.